Skip to main content

Table 1 Characteristics of patients at ICU admission

From: Galectin-3 in septic acute kidney injury: a translational study

Variable All patients (n = 57) Patients without subsequent AKI (n = 30) Patients with subsequent AKI (n = 27) P value
Age (years) 59 (53–66) 59 (53–66.8) 61 (55–66) 0.53
Female sex, n (%) 32 (56) 18 (60) 14 (52) 0.73
ICU stay (days) 13 (9–15) 11 (8.3–13) 15 (11.5–19.5)  < 0.001
APACHE II score 16 (12–21) 14 (11–17) 20 (13.5–23)  < 0.05
Serum Gal-3 (ng/ml) 5.7 (3.6–8.9) 4.2 (3.5–7) 7.9 (4.7–16.6) 0.002
Serum CysC (μg/ml) 1.5 (1.1–2.2) 1.2 (0.9–1.5) 2 (1.7–4.1) 0.002
Serum NGAL (ng/ml) 302.9 (175.3–514.2) 243.4 (170.6–421.9) 430 (215–561) 0.406
Serum PCT (ng/ml) 11.2 (3.1–52.4) 7.7 (2.9–27.3) 32.6 (3.7–91) 0.007
  1. Characteristics of patients in AKI and non-AKI groups. Characteristics were compared using chi-square tests or two-tailed t-tests. AKI acute kidney injury, APACHE II acute physiology and chronic health evaluation II, CysC cystatin C, Gal-3 galectin-3, ICU intensive care unit, NGAL neutrophil gelatinase-associated lipocalin, PCT procalcitonin